Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Silence Therapeutics
(SLN) Q4 2024
Earnings
SLN
Nov 14
Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.09
-0.06
-0.03
-0.01
Details
Expected EPS
-0.04379731
Actual EPS
-0.08513551
Surprise EPS
-0.04
Surprise Percent
-94.39%
Description
Silence Therapeutics (SLN) has reported earnings of -0.08513551 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login